Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the… […]
Keyword: OUD
Starting an Effective PHN/PCMH Model to End the Syndemic | October 26, 2022
In this series of presentations Dawn Benth, RN, Casey Marlin, PharmD, and Kelsey Kroon, PharmD share the story of their facility’s program to end the syndemic using a public health… […]
Read More… from Starting an Effective PHN/PCMH Model to End the Syndemic | October 26, 2022
Starting and Expanding MAT Programs | October 25, 2022
In this discussion, Dr. Ashely Quanbeck, MD, and Dr. Bradley Moran, PharmD, share on their efforts and lessons learned in starting Medications for Opioid Use Disorder Programs (MOUD). Dr. Moran… […]
Read More… from Starting and Expanding MAT Programs | October 25, 2022
Buprenorphine: Prescribing and Review of Literature (Part 2) | August 3, 2022
In this presentation, Dr. Jasen Christensen presents on buprenorphine and other options for managing opioid use disorder. Dr. Christensen reviews buprenorphine induction, literature informing current prescribing best practices, and discusses… […]
Read More… from Buprenorphine: Prescribing and Review of Literature (Part 2) | August 3, 2022
Effectively Addressing the Opioid Crisis in Indian Country | June 23, 2022
This 3-hour virtual training program provides comprehensive information to effectively integrate evidence-based substance use disorder (SUD) treatment and recovery services with holistic, culturally appropriate care. ECHO faculty discuss Indigenous Trauma… […]
Read More… from Effectively Addressing the Opioid Crisis in Indian Country | June 23, 2022
Harm Reduction, SSPs, and Me | May 5, 2022
In this presentation, Jessica Rienstra, RN, BSN, discusses the goals of Harm Reduction and how it is used throughout healthcare and in our daily lives. She also discusses the cost… […]
Opioid Withdrawal Management | May 3, 2022
In this presentation, Dr. Hannah Moses, PharmD, discusses opioid withdrawal management. Dr. Moses defines opioid withdrawal management, identifies signs and symptoms of opioid withdrawal, and reviews treatment options for withdrawal… […]
Microdose Buprenorphine Induction | April 7, 2022
In this presentation, Dr. Jonathan Robbins, MD, defines buprenorphine microdosing and several protocols for microinduction. Additionally, case studies from both inpatient and outpatient settings are reviewed as well as guidelines… […]
Read More… from Microdose Buprenorphine Induction | April 7, 2022
MAT and the HCV Provider | March 23, 2022
In this presentation Dr. Jessica Gregg provides an overview of screening, treatment options, and individualized care for patients with substance use disorder and hepatitis C virus. The trifecta of interventions… […]
Effectively Addressing the Opioid Crisis in Indian Country | February 24, 2022
This 3-hour virtual training program provides comprehensive information to effectively integrate evidence-based substance use disorder (SUD) treatment and recovery services with holistic, culturally appropriate care. ECHO faculty discuss Indigenous Trauma… […]
Read More… from Effectively Addressing the Opioid Crisis in Indian Country | February 24, 2022
